Studies reported that CYB561 is highly expressed in tissues of breast cancer patients and correlates with poor prognosis [11], and low expressed in endometrial cancer and ovarian cancer, also correlating with poor prognosis [12, 13]. This evidence concerns the gene CYB561 and breast carcinoma.